ReviewDiseases (Basel, Switzerland)2018

Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies.

Giovanni Ciccarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.